Migraine without aura

• Long-term Extension Study to Assess Adverse Events and Tolerability of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Ag … Recruiting
  2022-501099-24-00 5 2023-12-22 "Migraine"
• A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) … Recruiting
  2022-501100-94-00 5 2023-11-08 "Episodic Migraine"
• A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults Recruiting
  2025-525125-12-00 2 2026-05-05 "Migraine with or without aura"
• Open- label study in children and adolescents with migraine: Acute Treatment Recruiting
  2024-512744-32-00 5 2022-02-01 "Acute Migraine (with or without aura)"
• A Study to Learn About the Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Children and Adolescents. Recruiting
  2024-512743-23-00 5 2021-08-31 "Acute Migraine (with or without aura)"
• Randomized, Double-Blind, Placebo-Controlled, Multiple-Attack Study with an Open-Label Extension to Evaluate the Efficacy, Safety, Tolerabil … Recruitment ended
  2023-506029-12-00 5 2024-04-03 "Migraine"
• Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events and Disease Activity in Adult Participants With Migraine … Recruitment ended
  2022-501172-25-00 5 2024-01-17 "Chronic and Episodic Migraine"
• Phase 3 Open label clinical trial with oral Atogepant for the prevention of migraine Ended
  2023-507096-21-00 5 2021-08-16 "Chronic or Episodic Migraine (Migraine without aura, migrain"

Showing 1–8 of 8 trials